Articles by Disease (Hematological Malignancies)

Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed

Journal: Current Drug Targets
Volume: 20
Page: 1091-1111
Author(s): Maryam Zanjirband* and Soheila Rahgozar

PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism

Journal: Current Drug Targets
Volume: 20
Page: 1281-1294
Author(s): Sana Shafi, Pawan Gupta, Gopal Lal Khatik and Jeena Gupta*

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14
Page: 113-132
Author(s): Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*

An Overview of HDAC Inhibitors and their Synthetic Routes

Journal: Current Topics in Medicinal Chemistry
Volume: 19
Page: 1005-1040
Author(s): Xiaopeng Peng, Guochao Liao, Pinghua Sun, Zhiqiang Yu and Jianjun Chen*

Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 19
Page: 995-1004
Author(s): Yu Bai, Daid Ahmad, Ting Wang*, Guihua Cui and Wenliang Li*

The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 26
Page: 2208-2229
Author(s): Dora Visnjic*, Vilma Dembitz and Hrvoje Lalic

Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia

Journal: Infectious Disorders - Drug Targets
Volume: 19
Page: 133-140
Author(s): Adel A. Hagag*, Walid A. El Shehaby, Aml I. El-Abasy and Maaly M. Mabrouk